Mark Alan Goldberg Insider Trading $LIFE aTYR PHARMA INC

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Mark Alan Goldberg.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Mark Alan Goldberg. Mark Alan Goldberg is Director in IMMUNOGEN INC ($IMGN) and Director in IDERA PHARMACEUTICALS, INC. ($IDRA) and Director in GLYCOMIMETICS INC ($GLYC) and Director in aTYR PHARMA INC ($LIFE) and Director in Blueprint Medicines Corp ($BPMC) and Director in Audentes Therapeutics, Inc. ($BOLD).

Mark Alan Goldberg in aTYR PHARMA INC

Trading Symbol: LIFE
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Mark Alan Goldberg: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: May 11 2017
$LIFE Market Capitalization: $78.27M
$LIFE Previous Close: $3.40

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Mark Alan Goldberg in aTYR PHARMA INC

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, LIFE, BOLD, BPMC, GLYC, IDRA, IMGN

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares
May 11 2017	LIFE	aTYR PHARMA INC	Goldberg Mark Alan	Director	Option Exercise	A	3.15	20,000	63,000	20,000
May 26 2016	LIFE	aTYR PHARMA INC	Goldberg Mark Alan	Director	Option Exercise	A	3.33	18,000	59,940	18,000
Jan 29 2016	LIFE	aTYR PHARMA INC	Goldberg Mark Alan	Director	Option Exercise	A	6.14	19,428	119,288	19,428
Jul 10 2015	LIFE	aTYR PHARMA INC	Goldberg Mark Alan	Director	Option Exercise	A	14.96	6,286	94,039	6,286

Page: 1